Ana León

机构：Baptist Hospital of Miami, Universidad Católica de Cuenca, Baptist Health South Florida · ORCID：0009-0005-2767-2274

发表论文 41 篇 · 总被引 518 次 · h-index 11

代表论文

• Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab (2013 · Journal of Clinical Oncology · 被引 197)
• Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab (2018 · The Oncologist · 被引 58)
• MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer (2015 · International Journal of Colorectal Disease · 被引 47)
• MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer (2016 · International Journal of Molecular Sciences · 被引 32)
• Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy (2015 · Molecular Diagnosis & Therapy · 被引 26)
• Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting (2020 · Clinical & Translational Oncology · 被引 20)